Dihydropyrimidine dehydrogenase mutation in neoadjuvant chemotherapy in head and neck cancers: Myth or reality?

PURPOSE: The docetaxel, 5-fluorouracil (5-FU), and cisplatin (TPF) regimen in India is associated with high percentages of Grade 3–4 toxicity. This analysis was planned to evaluate the incidence of dihydropyrimidine dehydrogenase (DPD) mutation in patients with severe gastrointestinal toxicity, to a...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:South Asian J Cancer
Huvudupphovsmän: Patil, Vijay M., Noronha, Vanita, Joshi, Amit, Zanwar, Saurabh, Ramaswamy, Anant, Arya, Supreeta, Mahajan, Abhishek, Bhattacharjee, Atanu, Prabhash, Kumar
Materialtyp: Artigo
Språk:Inglês
Publicerad: Medknow Publications & Media Pvt Ltd 2016
Ämnen:
HEAD AND NECK CANCER: Original Article
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5184753/
https://ncbi.nlm.nih.gov/pubmed/28032083
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2278-330X.195338
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk